Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 10, 2026 13:00 ET | Source: DelveInsight Business Research LLP

Metastatic Prostate Cancer Market Set for Robust Growth Through 2036, Driven by The Emergence of PARP Inhibitors and PSMA-targeted Radioligand Therapies | DelveInsight

New York, USA, June 10, 2026 (GLOBE NEWSWIRE) -- Metastatic Prostate Cancer Market Set for Robust Growth Through 2036, Driven by The Emergence of PARP Inhibitors and PSMA-targeted Radioligand...
June 10, 2026 13:00 ET | Source: DelveInsight Business Research LLP

Lupus Nephritis Clinical Trial Landscape Becomes Increasingly Crowded with 30+ Pharma Companies | DelveInsight

New York, USA, June 10, 2026 (GLOBE NEWSWIRE) -- Lupus Nephritis Clinical Trial Landscape Becomes Increasingly Crowded with 30+ Pharma Companies | DelveInsight The lupus nephritis clinical trial...
June 09, 2026 13:00 ET | Source: DelveInsight Business Research LLP

Treg Cell-Based Therapies Clinical Trial Pipeline Appears Robust With 29+ Key Pharma Companies Actively Working in the Domain | DelveInsight

New York, USA, June 09, 2026 (GLOBE NEWSWIRE) -- Treg Cell-Based Therapies Clinical Trial Pipeline Appears Robust With 29+ Key Pharma Companies Actively Working in the Domain | DelveInsight The...
June 08, 2026 13:00 ET | Source: DelveInsight Business Research LLP

Alcohol Use Disorder Market Set to Expand at a 12.1% CAGR During the Forecast Period (2026–2036), Owing to the Emergence of Novel Mechanisms Such as 5-HT3 Pathway, NOP Receptor, mGluR5 NAM, and Other | DelveInsight

New York, USA, June 08, 2026 (GLOBE NEWSWIRE) -- Alcohol Use Disorder Market Set to Expand at a 12.1% CAGR During the Forecast Period (2026–2036), Owing to the Emergence of Novel Mechanisms Such as...
June 04, 2026 13:00 ET | Source: DelveInsight Business Research LLP

IgE Receptor Antagonists Clinical Trial Pipeline Analysis: 12+ Key Companies Shaping the Future of IgE Receptor Antagonists Therapeutics | DelveInsight

New York, USA, June 04, 2026 (GLOBE NEWSWIRE) -- IgE Receptor Antagonists Clinical Trial Pipeline Analysis: 12+ Key Companies Shaping the Future of IgE Receptor Antagonists Therapeutics |...
June 03, 2026 13:00 ET | Source: DelveInsight Business Research LLP

Acute Respiratory Distress Syndrome Market to Grow Steadily at a 3.8% CAGR Through 2036, Supported by Emerging ARDS Therapies | DelveInsight

New York, USA, June 03, 2026 (GLOBE NEWSWIRE) -- Acute Respiratory Distress Syndrome Market to Grow Steadily at a 3.8% CAGR Through 2036, Supported by Emerging ARDS Therapies | DelveInsight The...
June 02, 2026 13:00 ET | Source: DelveInsight Business Research LLP

Myasthenia Gravis Clinical Trial Pipeline Expands as 25+ Companies Race to Redefine Myasthenia Gravis Treatment Landscape | DelveInsight

New York, USA, June 02, 2026 (GLOBE NEWSWIRE) -- Myasthenia Gravis Clinical Trial Pipeline Expands as 25+ Companies Race to Redefine Myasthenia Gravis Treatment Landscape | DelveInsight The...
June 01, 2026 13:00 ET | Source: DelveInsight Business Research LLP

Metastatic HER2-Positive Breast Cancer Market Expected to Surge at a CAGR of 8.3% During the Forecast Period (2026–2036) Due to Advancing Targeted Treatments | DelveInsight

New York, USA, June 01, 2026 (GLOBE NEWSWIRE) -- Metastatic HER2-Positive Breast Cancer Market Expected to Surge at a CAGR of 8.3% During the Forecast Period (2026–2036) Due to Advancing Targeted...
May 28, 2026 13:00 ET | Source: DelveInsight Business Research LLP

Synovial Sarcoma Clinical Trial Pipeline Accelerates as 15+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

New York, USA, May 28, 2026 (GLOBE NEWSWIRE) -- Synovial Sarcoma Clinical Trial Pipeline Accelerates as 15+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight The synovial...
May 27, 2026 13:00 ET | Source: DelveInsight Business Research LLP

Glioblastoma Multiforme Market Poised for Significant Growth at a CAGR of 13.2% During the Forecast Period (2026–2036), as Next-Generation Therapies Enter Late-Stage Development | DelveInsight

New York, USA, May 27, 2026 (GLOBE NEWSWIRE) -- Glioblastoma Multiforme Market Poised for Significant Growth at a CAGR of 13.2% During the Forecast Period (2026–2036), as Next-Generation Therapies...